The emerging treatment of the medication represents a significant breakthrough in the care of type 2 diabetes. Different to existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide234798.bloggactif.com/43511814/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment